- Home
- CLPR vs BEAT Comparison
CLPR vs BEAT Comparison
Compare CLPR & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPR | BEAT |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 53.2M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLPR | BEAT |
|---|---|---|
| Price | $2.89 | $0.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 170.9K | ★ 598.8K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,997,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.82 | N/A |
| 52 Week Low | $2.69 | $0.51 |
| 52 Week High | $4.61 | $4.00 |
Technical Indicators
Market Signals| Indicator | CLPR | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 37.32 |
| Support Level | $2.85 | $0.54 |
| Resistance Level | $3.33 | $0.79 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 50.42 | 25.49 |
Price Performance
Historical ComparisonAbout CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.